
In first open-label phase 3 data from the ADEPT program, KarXT cut hallucination and delusion scores in Alzheimer disease psychosis, with no new safety signals.
10 Things Docs Want To Tell Their Families
Physicians Practice
Merging Administrative and Academic Careers in Psychiatry
Psychiatric Times
Take This Job and Shove It
Physicians Practice
Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
Psychiatric Times
12 Tips for Making Your Practice Greener
Physicians Practice
Managing Risks When Practicing in Three-Party Care Settings
Psychiatric Times
More career resources >>




